Connect Biopharma Holdings Ltd [CNTB] stock prices are up 26.19% to $2.12 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CNTB shares have gain 36.77% over the last week, with a monthly amount glided 15.85%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Connect Biopharma Holdings Ltd [NASDAQ: CNTB] stock has seen the most recent analyst activity on October 31, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $10. Previously, H.C. Wainwright started tracking the stock with Buy rating on June 12, 2025, and set its price target to $7. On March 04, 2024, H.C. Wainwright initiated with a Buy rating and assigned a price target of $7 on the stock. SVB Leerink started tracking the stock assigning a Outperform rating and suggested a price target of $32 on April 13, 2021. Piper Sandler initiated its recommendation with a Overweight. Jefferies started tracking with a Buy rating for this stock on April 13, 2021, and assigned it a price target of $27.
The stock price of Connect Biopharma Holdings Ltd [CNTB] has been fluctuating between $0.51 and $2.86 over the past year. Currently, Wall Street analysts expect the stock to reach $1.5 within the next 12 months. Connect Biopharma Holdings Ltd [NASDAQ: CNTB] shares were valued at $2.12 at the most recent close of the market. An investor can expect a potential drop of -29.25% based on the average CNTB price forecast.
Analyzing the CNTB fundamentals
Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -19.56%, Pretax Profit Margin comes in at -18.31%, and Net Profit Margin reading is -18.43%. To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -0.44 and Total Capital is -0.53. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.75 points at the first support level, and at 1.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.33, and for the 2nd resistance point, it is at 2.54.
Ratios To Look Out For
It’s worth pointing out that Connect Biopharma Holdings Ltd [NASDAQ:CNTB]’s Current Ratio is 5.48. On the other hand, the Quick Ratio is 5.48, and the Cash Ratio is 3.78. Considering the valuation of this stock, the price to sales ratio is 4.54, the price to book ratio is 2.14.
Transactions by insiders
Recent insider trading involved Wei Zheng, 10% Owner, that happened on Oct 01 ’25 when 0.2 million shares were purchased. 10% Owner, Wei Zheng completed a deal on Jun 11 ’25 to buy 39775.0 shares.
